⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 2, 2024Open Access

Supplementary Figure 6 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma

Joshua P. Plotnik Adam E. Richardson Haopeng Yang Estela Rojas Velitchka Bontcheva Colleen Dowell Sydney Parsons Ashley Wilson Vida Ravanmehr Christine Will Paul Jung Haizhong Zhu Sarathy Karunan Partha Sanjay C. Panchal Raghuveer Singh Mali Frederick J. Kohlhapp Ryan A. McClure Cyril Y. Ramathal Mariam D. George Manisha A. Jhala Nathaniel L. Elsen Wei Qiu Russell A. Judge Chin Pan Anthony Mastracchio Jared Henderson Jonathan A. Meulbroek Michael R. Green William N. Pappano

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

In vitro and in vivo combination of ABBV-MALT1 and venetoclax

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Plotnik et al. (2024) studied this question.

synapsesocial.com/papers/68e61b6eb6db6435875adaca https://doi.org/10.1158/1535-7163.26145146

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 6 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
2Supplementary Figure 4 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
3Supplementary Figure 4 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
4Supplementary Figure 3 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
5Supplementary Figure 3 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024

More related papers

Supplementary Figure 5 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
Supplementary Figure 5 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024
Supplementary Figure 7 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma2024